A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
Verstovsek, Srdan, Mesa, Ruben A, Gotlib, Jason, Levy, Richard S, Gupta, Vikas, DiPersio, John F, Catalano, John V, Deininger, Michael, Miller, Carole, Silver, Richard T, Talpaz, Moshe, Winton, Elliott F, Harvey, Jimmie H, Arcasoy, Murat O, Hexner, Elizabeth, Lyons, Roger M, Paquette, Ronald, Raza, Azra, Vaddi, Kris, Erickson-Viitanen, Susan, Koumenis, Iphigenia L, Sun, William, Sandor, Victor, Kantarjian, Hagop M
Published in The New England journal of medicine (01.03.2012)
Published in The New England journal of medicine (01.03.2012)
Get full text
Journal Article
Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias
Cortes, Jorge E, Kantarjian, Hagop, Shah, Neil P, Bixby, Dale, Mauro, Michael J, Flinn, Ian, O'Hare, Thomas, Hu, Simin, Narasimhan, Narayana I, Rivera, Victor M, Clackson, Tim, Turner, Christopher D, Haluska, Frank G, Druker, Brian J, Deininger, Michael W.N, Talpaz, Moshe
Published in The New England journal of medicine (29.11.2012)
Published in The New England journal of medicine (29.11.2012)
Get full text
Journal Article
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial
Cortes, Jorge, Apperley, Jane, Lomaia, Elza, Moiraghi, Beatriz, Undurraga Sutton, Maria, Pavlovsky, Carolina, Chuah, Charles, Sacha, Tomasz, Lipton, Jeffrey H., Schiffer, Charles A., McCloskey, James, Hochhaus, Andreas, Rousselot, Philippe, Rosti, Gianantonio, de Lavallade, Hugues, Turkina, Anna, Rojas, Christine, Arthur, Christopher Kevin, Maness, Lori, Talpaz, Moshe, Mauro, Michael, Hall, Tracey, Lu, Vickie, Srivastava, Shouryadeep, Deininger, Michael
Published in Blood (25.11.2021)
Published in Blood (25.11.2021)
Get full text
Journal Article
Dasatinib dose management for the treatment of chronic myeloid leukemia
Talpaz, Moshe, Saglio, Giuseppe, Atallah, Ehab, Rousselot, Philippe
Published in Cancer (15.04.2018)
Published in Cancer (15.04.2018)
Get full text
Journal Article
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Robinson, Dan R, Wu, Yi-Mi, Vats, Pankaj, Su, Fengyun, Lonigro, Robert J, Cao, Xuhong, Kalyana-Sundaram, Shanker, Wang, Rui, Ning, Yu, Hodges, Lynda, Gursky, Amy, Siddiqui, Javed, Tomlins, Scott A, Roychowdhury, Sameek, Pienta, Kenneth J, Kim, Scott Y, Roberts, J Scott, Rae, James M, Van Poznak, Catherine H, Hayes, Daniel F, Chugh, Rashmi, Kunju, Lakshmi P, Talpaz, Moshe, Schott, Anne F, Chinnaiyan, Arul M
Published in Nature genetics (01.12.2013)
Published in Nature genetics (01.12.2013)
Get full text
Journal Article
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
Robinson, Dan R, Wu, Yi-Mi, Kalyana-Sundaram, Shanker, Cao, Xuhong, Lonigro, Robert J, Sung, Yun-Shao, Chen, Chun-Liang, Zhang, Lei, Wang, Rui, Su, Fengyun, Iyer, Matthew K, Roychowdhury, Sameek, Siddiqui, Javed, Pienta, Kenneth J, Kunju, Lakshmi P, Talpaz, Moshe, Mosquera, Juan Miguel, Singer, Samuel, Schuetze, Scott M, Antonescu, Cristina R, Chinnaiyan, Arul M
Published in Nature genetics (01.02.2013)
Published in Nature genetics (01.02.2013)
Get full text
Journal Article
The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma
Raab, Marc S., Thomas, Sheeba K., Ocio, Enrique M., Guenther, Andreas, Goh, Yeow-Tee, Talpaz, Moshe, Hohmann, Nicolas, Zhao, Sylvia, Xiang, Fang, Simon, Carl, Vanasse, K. Gary, Kumar, Shaji K.
Published in Leukemia (01.12.2019)
Published in Leukemia (01.12.2019)
Get full text
Journal Article
Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo
Borkin, Dmitry, He, Shihan, Miao, Hongzhi, Kempinska, Katarzyna, Pollock, Jonathan, Chase, Jennifer, Purohit, Trupta, Malik, Bhavna, Zhao, Ting, Wang, Jingya, Wen, Bo, Zong, Hongliang, Jones, Morgan, Danet-Desnoyers, Gwenn, Guzman, Monica L., Talpaz, Moshe, Bixby, Dale L., Sun, Duxin, Hess, Jay L., Muntean, Andrew G., Maillard, Ivan, Cierpicki, Tomasz, Grembecka, Jolanta
Published in Cancer cell (13.04.2015)
Published in Cancer cell (13.04.2015)
Get full text
Journal Article
Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients
Richardson, Paul G., Baz, Rachid, Wang, Michael, Jakubowiak, Andrzej J., Laubach, Jacob P., Harvey, R. Donald, Talpaz, Moshe, Berg, Deborah, Liu, Guohui, Yu, Jiang, Gupta, Neeraj, Di Bacco, Alessandra, Hui, Ai-Min, Lonial, Sagar
Published in Blood (14.08.2014)
Published in Blood (14.08.2014)
Get full text
Journal Article
Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience
Kantarjian, Hagop, O'Brien, Susan, Jabbour, Elias, Garcia-Manero, Guillermo, Quintas-Cardama, Alfonso, Shan, Jenny, Rios, Mary Beth, Ravandi, Farhad, Faderl, Stefan, Kadia, Tapan, Borthakur, Gautam, Huang, Xuelin, Champlin, Richard, Talpaz, Moshe, Cortes, Jorge
Published in Blood (01.03.2012)
Published in Blood (01.03.2012)
Get full text
Journal Article
Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia
Verstovsek, Srdan, Mesa, Ruben, Talpaz, Moshe, Kiladjian, Jean-Jacques, Harrison, Claire N., Oh, Stephen T., Vannucchi, Alessandro M., Rampal, Raajit, Scott, Bart L., Buckley, Sarah A., Craig, Adam R., Roman-Torres, Karisse, Mascarenhas, John O.
Published in Haematologica (Roma) (01.07.2022)
Published in Haematologica (Roma) (01.07.2022)
Get full text
Journal Article
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial
Verstovsek, Srdan, Mesa, Ruben A, Gotlib, Jason, Gupta, Vikas, DiPersio, John F, Catalano, John V, Deininger, Michael W N, Miller, Carole B, Silver, Richard T, Talpaz, Moshe, Winton, Elliott F, Harvey, Jr, Jimmie H, Arcasoy, Murat O, Hexner, Elizabeth O, Lyons, Roger M, Paquette, Ronald, Raza, Azra, Jones, Mark, Kornacki, Deanna, Sun, Kang, Kantarjian, Hagop
Published in Journal of hematology and oncology (22.02.2017)
Published in Journal of hematology and oncology (22.02.2017)
Get full text
Journal Article
Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis
PARDANANI, Animesh, GOTLIB, Jason R, JAMIESON, Catriona, CORTES, Jorge E, TALPAZ, Moshe, STONE, Richard M, SILVERMAN, Michael H, GILLILAND, D. Gary, SHORR, Jolene, TEFFERI, Ayalew
Published in Journal of clinical oncology (01.03.2011)
Published in Journal of clinical oncology (01.03.2011)
Get full text
Journal Article
Identification of targetable FGFR gene fusions in diverse cancers
Wu, Yi-Mi, Su, Fengyun, Kalyana-Sundaram, Shanker, Khazanov, Nickolay, Ateeq, Bushra, Cao, Xuhong, Lonigro, Robert J, Vats, Pankaj, Wang, Rui, Lin, Su-Fang, Cheng, Ann-Joy, Kunju, Lakshmi P, Siddiqui, Javed, Tomlins, Scott A, Wyngaard, Peter, Sadis, Seth, Roychowdhury, Sameek, Hussain, Maha H, Feng, Felix Y, Zalupski, Mark M, Talpaz, Moshe, Pienta, Kenneth J, Rhodes, Daniel R, Robinson, Dan R, Chinnaiyan, Arul M
Published in Cancer discovery (01.06.2013)
Published in Cancer discovery (01.06.2013)
Get full text
Journal Article
Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study
Harrison, Claire N, Schaap, Nicolaas, Vannucchi, Alessandro M, Kiladjian, Jean-Jacques, Tiu, Ramon V, Zachee, Pierre, Jourdan, Eric, Winton, Elliott, Silver, Richard T, Schouten, Harry C, Passamonti, Francesco, Zweegman, Sonja, Talpaz, Moshe, Lager, Joanne, Shun, Zhenming, Mesa, Ruben A
Published in The Lancet. Haematology (01.07.2017)
Published in The Lancet. Haematology (01.07.2017)
Get more information
Journal Article
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis
Mascarenhas, John O, Talpaz, Moshe, Gupta, Vikas, Foltz, Lynda M, Savona, Michael R, Paquette, Ronald, Turner, A Robert, Coughlin, Paul, Winton, Elliott, Burn, Timothy C, O'Neill, Peter, Clark, Jason, Hunter, Deborah, Assad, Albert, Hoffman, Ronald, Verstovsek, Srdan
Published in Haematologica (Roma) (01.02.2017)
Published in Haematologica (Roma) (01.02.2017)
Get full text
Journal Article
CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
Burgos-Ojeda, Daniela, Wu, Rong, McLean, Karen, Chen, Yu-Chih, Talpaz, Moshe, Yoon, Euisik, Cho, Kathleen R, Buckanovich, Ronald J
Published in Molecular cancer therapeutics (01.07.2015)
Published in Molecular cancer therapeutics (01.07.2015)
Get full text
Journal Article